Viking Therapeutics (VKTX) Amortization - Intangibles (2014 - 2018)

Viking Therapeutics has disclosed Amortization - Intangibles across 5 years of filings, most recently posting $146000.0 for Q2 2018.

• Amortization - Intangibles for Q2 2018 came in at $146000.0, down 56.68% year-over-year; the trailing twelve-month figure through Mar 2019 was $146000.0 (down 86.85% YoY), and the FY2018 annual result was $404000.0, down 68.51% from the prior year.
• Amortization - Intangibles came in at $146000.0 for Q2 2018 at Viking Therapeutics, down from $258000.0 in the prior quarter.
• In the past five years, Amortization - Intangibles ranged from a high of $524977.0 in Q2 2016 to a low of $6379.0 in Q1 2014.
• The 5-year median for Amortization - Intangibles is $257000.0 (2017), against an average of $273697.2.
• Across the five-year window, Amortization - Intangibles surged 2595.64% in 2015 and sank 56.68% in 2018, its largest moves.
• Viking Therapeutics' Amortization - Intangibles stood at $294310.0 in 2014, then fell by 18.28% to $240516.0 in 2015, then surged by 79.29% to $431227.0 in 2016, then sank by 39.94% to $259000.0 in 2017, then sank by 43.63% to $146000.0 in 2018.
• The last three Amortization - Intangibles figures came in at $146000.0 (Q2 2018), $258000.0 (Q1 2018), and $259000.0 (Q4 2017), per Business Quant data.